More S'poreans Going Abroad for IVF to Choose Baby's Gender
By Asia One,
Asia One
| 08. 22. 2011
More and more Singaporeans are heading overseas for medical procedures which allow them to choose their babies' gender.
According to The Straits Times, foreign destinations such as the United States, and increasingly Thailand, let parents choose the gender of their babies through a procedure known as preimplantation genetic diagnosis (PGD), which is banned in Singapore.
These places are also well-known for their skills in in-vitro fertilisation (IVF).
Having sons important for people of Chinese ancestry
The managing director of Marvel IVF Solutions, an IVF facility in Bangkok, said 90 per cent of Singaporeans, Chinese nationals and Hong Kongers ask for boys.
That is because males are seen as heirs and capable of taking care of their siblings, the director said.
Other facilities such as Safe Fertility and PGD Centre in Bangkok and Fertility Institutes in Los Angeles also saw the same requests by Singaporean patrons, according to The Straits Times.
Embryos screened for gender or genetic diseases or both
PGD is carried out with IVF treatment and the embryos are screened for gender or genetic diseases or both, during the...
Related Articles
By Adithi Ramakrishnan, AP News | 08.05.2026
NEW YORK (AP) — Matt Walker couldn’t pet a dog without sneezing — until he and other scientists used a gene editing technique to produce a hypoallergenic beagle named Bailey.
Now, he can feed Bailey spoons of peanut butter while...
By Brendan Borrell, Science | 07.23.2026
The young girl tugged on her mother’s hand as they pressed through the doors of the hospital in Shanghai. She was 6 years old, bouncing along in a pink jacket and blue pants decorated with cartoon bears. Behind them, her...
By Matthew Herper, Stat | 07.01.2026
Researchers have created what they say may count as the first synthetic cell, and have started a public benefit corporation to share the technology with other scientists. It’s a piece of science that generates as many questions as answers. They...
By Darren Incorvaia, Fierce Biotech | 07.16.2026
Jennifer Doudna, Ph.D., the Nobel Laureate best known for co-inventing the CRISPR system that has become the foundation for gene editing, is dipping her toes into a new, buzzy field: AI-powered protein design.
In a new paper, published today...